Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (1)
  • Drug Metabolite
    (1)
  • JNK
    (1)
  • Others
    (2)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
  • Others
    (1)
Filter
Search Result
Results for "

8-hydroxy efavirenz

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • Cell Research
    1
    TargetMol | Cell_Research_Reagents
  • Reference Standards
    1
    TargetMol | Standard_Products
  • 8-hydroxy Efavirenz
    T37162205754-33-2
    8-hydroxy Efavirenz is a major oxidative metabolite of the non-nucleoside reverse transcriptase inhibitor efavirenz . 8-hydroxy Efavirenz is formed when efavirenz is metabolized by the cytochrome P450 (CYP) isoform CYP2B6. It induces apoptosis in rat primary hippocampal neurons and loss of dendritic spines in rat primary hippocampal neuronal cultures when used at a concentration of 0.01 μM.
    • $1,510
    35 days
    Size
    QTY
  • 8-hydroxy Efavirenz (Standard)
    TMSM-3452205754-33-2
    8-hydroxy Efavirenz (Standard) is a reference standard for research and analysis in studies involving 8-hydroxy Efavirenz. 8-hydroxy Efavirenz is a major oxidative metabolite of the non-nucleoside reverse transcriptase inhibitor efavirenz . 8-hydroxy Efavirenz is formed when efavirenz is metabolized by the cytochrome P450 (CYP) isoform CYP2B6. It induces apoptosis in rat primary hippocampal neurons and loss of dendritic spines in rat primary hippocampal neuronal cultures when used at a concentration of 0.01 μM.
    • $945
    4-6 weeks
    Size
    QTY
  • (Rac)-8-Hydroxy-efavirenz
    TYD-02043205754-32-1
    (Rac)-8-Hydroxy-efavirenz is a metabolite of Efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV-1.
    • Inquiry Price
    10-14 weeks
    Size
    QTY